SLC5A2 and type 2 diabetes mellitus: Based on these findings, our results now indicate that even a brief, 4-week SGLT-2 inhibitor therapy may induce measurable improvements in hydroxyl-free-radical-driven amino acid modifications while concurrently improving current perception threshold (CPT) values in patients with type 2 diabetes who initially exhibited abnormal (above-range) CPT values.